help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kleihues, P.
Right arrow Articles by Ohgaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleihues, P.
Right arrow Articles by Ohgaki, H.

American Journal of Pathology, Vol 150, 1-13, Copyright © 1997 by American Society for Investigative Pathology

REVIEWS

Tumors associated with p53 germline mutations: a synopsis of 91 families

P Kleihues, B Schauble, A zur Hausen, J Esteve and H Ohgaki
International Agency for Research on Cancer, Lyon, France.

Although inherited p53 mutations are present in all somatic cells, malignant transformation is limited to certain organs and target cells. The analysis of 475 tumors in 91 families with p53 germline mutations reported since 1990 shows that breast carcinomas are most frequent (24.0%), followed by bone sarcomas (12.6%), brain tumors (12.0%), and soft tissue sarcomas (11.6%). The sporadic counterparts of these tumors also carry a high incidence of p53 mutations, suggesting that in these tissues p53 mutations are capable of initiating the process of malignant transformation. Hematological neoplasms (acute lymphoblastic leukemia and Hodgkin's lymphoma) and adrenocortical carcinomas occurred at a frequency of 4.2 and 3.6%, respectively. One-half of the families fulfilled the diagnostic criteria of the Li-Fraumeni syndrome. There were marked organ-specific differences in the mean age at which carriers of p53 germline mutations present with neoplastic disease: 5 years for adrenocortical carcinomas, 16 years for sarcomas, 25 years for brain tumors, 37 years for breast cancer, and almost 50 years for lung cancer. Analysis of the mutational spectrum showed a predominance of G:C-->A:T transitions at CpG sites, suggesting an endogenous formation, eg, by deamination of 5-methylcytosine, rather than a causation by environmental mutagenic carcinogens. The location of mutations within the p53 gene was found to be similar to that of somatic mutations in sporadic tumors. There is no evidence of an organ or target cell specificity of p53 germline mutations; the occasional familial clustering of certain tumor types is more likely to reflect the genetic background of the respective kindred or the additional influence of environmental and nongenetic host factors.


This article has been cited by other articles:


Home page
 JAMAHome page
S. Masciari, A. D. Van den Abbeele, L. R. Diller, I. Rastarhuyeva, J. Yap, K. Schneider, L. Digianni, F. P. Li, J. F. Fraumeni Jr, S. Syngal, et al.
F18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome
JAMA, March 19, 2008; 299(11): 1315 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. Krex, B. Klink, C. Hartmann, A. von Deimling, T. Pietsch, M. Simon, M. Sabel, J. P. Steinbach, O. Heese, G. Reifenberger, et al.
Long-term survival with glioblastoma multiforme
Brain, October 1, 2007; 130(10): 2596 - 2606.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. N. West, G. A. Neale, S. Pounds, B. C. Figueredo, C. Rodriguez Galindo, M. A. D. Pianovski, A. G. Oliveira Filho, D. Malkin, E. Lalli, R. Ribeiro, et al.
Gene Expression Profiling of Childhood Adrenocortical Tumors
Cancer Res., January 15, 2007; 67(2): 600 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. P. Turner, S. Cortellino, J. E. Schupp, E. Caretti, T. Loh, T. J. Kinsella, and A. Bellacosa
The DNA N-Glycosylase MED1 Exhibits Preference for Halogenated Pyrimidines and Is Involved in the Cytotoxicity of 5-Iododeoxyuridine.
Cancer Res., August 1, 2006; 66(15): 7686 - 7693.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. N. West, R. C. Ribeiro, J. Jenkins, C. Rodriguez-Galindo, B. C. Figueiredo, R. Kriwacki, and G. P. Zambetti
Identification of a Novel Germ Line Variant Hotspot Mutant p53-R175L in Pediatric Adrenal Cortical Carcinoma.
Cancer Res., May 15, 2006; 66(10): 5056 - 5062.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
B C Figueiredo, R Sandrini, G P Zambetti, R M Pereira, C Cheng, W Liu, L Lacerda, M A Pianovski, E Michalkiewicz, J Jenkins, et al.
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation
J. Med. Genet., January 1, 2006; 43(1): 91 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
B. Malmer, M. Feychting, S. Lonn, A. Ahlbom, and R. Henriksson
p53 Genotypes and Risk of Glioma and Meningioma
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2220 - 2223.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
Y. YAMADA and C. R. COFFMAN
DNA Damage-Induced Programmed Cell Death: Potential Roles in Germ Cell Development
Ann. N.Y. Acad. Sci., May 1, 2005; 1049(1): 9 - 16.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
G Keller, H Vogelsang, I Becker, S Plaschke, K Ott, G Suriano, A R Mateus, R Seruca, K Biedermann, D Huntsman, et al.
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients
J. Med. Genet., June 1, 2004; 41(6): e89 - e89.
[Full Text] [PDF]

Home page
 JCOHome page
E. Michalkiewicz, R. Sandrini, B. Figueiredo, E.C.M. Miranda, E. Caran, A.G. Oliveira-Filho, R. Marques, M.A.D. Pianovski, L. Lacerda, L.M. Cristofani, et al.
Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry
J. Clin. Oncol., March 1, 2004; 22(5): 838 - 845.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
D. L. Thull and V. G. Vogel
Recognition and Management of Hereditary Breast Cancer Syndromes
Oncologist, February 1, 2004; 9(1): 13 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Olivier, D. E. Goldgar, N. Sodha, H. Ohgaki, P. Kleihues, P. Hainaut, and R. A. Eeles
Li-Fraumeni and Related Syndromes: Correlation between Tumor Type, Family Structure, and TP53 Genotype
Cancer Res., October 15, 2003; 63(20): 6643 - 6650.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. F. Lang, J. M. Bruner, G. N. Fuller, K. Aldape, M. D. Prados, S. Chang, M. S. Berger, M. W. McDermott, S. M. Kunwar, L. R. Junck, et al.
Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results
J. Clin. Oncol., July 1, 2003; 21(13): 2508 - 2518.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. C. Borden, L. H. Baker, R. S. Bell, V. Bramwell, G. D. Demetri, B. L. Eisenberg, C. D. M. Fletcher, J. A. Fletcher, M. Ladanyi, P. Meltzer, et al.
Soft Tissue Sarcomas of Adults: State of the Translational Science
Clin. Cancer Res., June 1, 2003; 9(6): 1941 - 1956.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. C. Blackburn, J. S. Brown, S. P. Naber, C. N. Otis, J. T. Wood, and D. J. Jerry
BALB/c Alleles for Prkdc and Cdkn2a Interact to Modify Tumor Susceptibility in Trp53+/- Mice
Cancer Res., May 15, 2003; 63(10): 2364 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
W.-M. Tong, H. Ohgaki, H. Huang, C. Granier, P. Kleihues, and Z.-Q. Wang
Null Mutation of DNA Strand Break-Binding Molecule Poly(ADP-ribose) Polymerase Causes Medulloblastomas in p53-/- Mice
Am. J. Pathol., January 1, 2003; 162(1): 343 - 352.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Wong, K. Yang, M. Kuraguchi, U. Werling, E. Avdievich, K. Fan, M. Fazzari, B. Jin, A. M. C. Brown, M. Lipkin, et al.
Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation
PNAS, November 12, 2002; 99(23): 14937 - 14942.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
G. Vlastos, N. Q. Mirza, F. Meric, K. K. Hunt, A. N. Mirza, L. A. Newman, F. C. Ames, H. M. Kuerer, M. I. Ross, B. Feig, et al.
Breast-Conservation Therapy in Early-Stage Breast Cancer Patients With a Positive Family History
Ann. Surg. Oncol., November 1, 2002; 9(9): 912 - 919.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. A. Bush and G. Li
Regulation of the Mdr1 isoforms in a p53-deficient mouse model
Carcinogenesis, October 1, 2002; 23(10): 1603 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
N. M. Hamad, J. H. Elconin, A. E. Karnoub, W. Bai, J. N. Rich, R. T. Abraham, C. J. Der, and C. M. Counter
Distinct requirements for Ras oncogenesis in human versus mouse cells
Genes & Dev., August 15, 2002; 16(16): 2045 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. H. Rickert, O. D. Wiestler, and W. Paulus
Chromosomal Imbalances in Choroid Plexus Tumors
Am. J. Pathol., March 1, 2002; 160(3): 1105 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Stankovic, G. S. Stewart, C. Fegan, P. Biggs, J. Last, P. J. Byrd, R. D. Keenan, P. A. H. Moss, and A. M. R. Taylor
Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage
Blood, January 1, 2002; 99(1): 300 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. G. Backlund, S. L. Trasti, D. C. Backlund, V. L. Cressman, V. Godfrey, and B. H. Koller
Impact of Ionizing Radiation and Genetic Background on Mammary Tumorigenesis in p53-deficient Mice
Cancer Res., September 1, 2001; 61(17): 6577 - 6582.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
P. R. Nambiar, M. L. Jackson, J. A. Ellis, B. J. Chelack, B. A. Kidney, and D. M. Haines
Immunohistochemical Detection of Tumor Suppressor Gene p53 Protein in Feline Injection Site-associated Sarcomas
Vet. Pathol., March 1, 2001; 38(2): 236 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. E. Nichols, D. Malkin, J. E. Garber, J. F. Fraumeni Jr., and F. P. Li
Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers
Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 83 - 87.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
C. Wetmore, D. E. Eberhart, and T. Curran
Loss of p53 but not ARF Accelerates Medulloblastoma in Mice Heterozygous for patched
Cancer Res., January 1, 2001; 61(2): 513 - 516.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
C. Kuperwasser, G. D. Hurlbut, F. S. Kittrell, E. S. Dickinson, R. Laucirica, D. Medina, S. P. Naber, and D. J. Jerry
Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice : A Model for Li-Fraumeni Syndrome
Am. J. Pathol., December 1, 2000; 157(6): 2151 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
C. Abate-Shen and M. M. Shen
Molecular genetics of prostate cancer
Genes & Dev., October 1, 2000; 14(19): 2410 - 2434.
[Full Text]

Home page
 Cancer Res.Home page
M. E. Hegi, M. A. Klein, D. Ruedi, P. Chene, M.-F. Hamou, and A. Aguzzi
p53 Transdominance But No Gain of Function in Mouse Brain Tumor Model
Cancer Res., June 1, 2000; 60(11): 3019 - 3024.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Wilkin, N. Gagné, J. Paquette, L. L. Oligny, and C. Deal
Pediatric Adrenocortical Tumors: Molecular Events Leading to Insulin-Like Growth Factor II Gene Overexpression
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2048 - 2056.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
C. Kuperwasser, J. Pinkas, G. D. Hurlbut, S. P. Naber, and D. J. Jerry
Cytoplasmic Sequestration and Functional Repression of p53 in the Mammary Epithelium Is Reversed by Hormonal Treatment
Cancer Res., May 1, 2000; 60(10): 2723 - 2729.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
S. Marino, M. Vooijs, H. van der Gulden, J. Jonkers, and A. Berns
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
Genes & Dev., April 15, 2000; 14(8): 994 - 1004.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
Z. Zhang, Q. Liu, L. E. Lantry, Y. Wang, G. J. Kelloff, M. W. Anderson, R. W. Wiseman, R. A. Lubet, and M. You
A Germ-Line p53 Mutation Accelerates Pulmonary Tumorigenesis: p53-independent Efficacy of Chemopreventive Agents Green Tea or Dexamethasone/myo-Inositol and Chemotherapeutic Agents Taxol or Adriamycin
Cancer Res., February 1, 2000; 60(4): 901 - 907.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
K.-M. Schulte, M. Mengel, M. Heinze, D. Simon, S. Scheuring, K. Köhrer, and H.-D. Röher
Complete Sequencing and Messenger Ribonucleic Acid Expression Analysis of the MEN I Gene in Adrenal Cancer
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 441 - 448.
[Abstract] [Full Text]

Home page
 ANN INTERN MEDHome page
S. R. Bornstein, C. A. Stratakis, and G. P. Chrousos
Adrenocortical Tumors: Recent Advances in Basic Concepts and Clinical Management
Ann Intern Med, May 4, 1999; 130(9): 759 - 771.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. C. Figueiredo, C. A. Stratakis, R. Sandrini, L. DeLacerda, M. A. D. Pianovsky, C. Giatzakis, H. M. Young, and B. R. Haddad
Comparative Genomic Hybridization Analysis of Adrenocortical Tumors of Childhood
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1116 - 1121.
[Abstract] [Full Text]

Home page
 NeurologyHome page
K. Fassbender, A. Ragoschke, S. Rossol, A. Schwartz, O. Mielke, A. Paulig, and M. Hennerici
Increased release of interleukin-12p40 in MS: Association with intracerebral inflammation
Neurology, September 1, 1998; 51(3): 753 - 758.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
A. Llombart-Bosch, A. Peydro-Olaya, C. Carda, C. Lopez-Gines, J. Boix-Ferrero, and A. Pellin
Primary Rhabdomyosarcoma Mimicking a Small Cell Sarcoma of Bone: A Nude Mice Xenograft, Cytogenetic, and Molecular Approach
International Journal of Surgical Pathology, April 1, 1998; 6(2): 61 - 71.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
F. Petronzelli, A. Riccio, G. D. Markham, S. H. Seeholzer, J. Stoerker, M. Genuardi, A. T. Yeung, Y. Matsumoto, and A. Bellacosa
Biphasic Kinetics of the Human DNA Repair Protein MED1 (MBD4), a Mismatch-specific DNA N-Glycosylase
J. Biol. Chem., October 13, 2000; 275(42): 32422 - 32429.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.